Green Cross Lab Cell Corporation (144510) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.015x

Based on the latest financial reports, Green Cross Lab Cell Corporation (144510) has a cash flow conversion efficiency ratio of 0.015x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩6.67 Billion ≈ $4.52 Million USD) by net assets (₩431.56 Billion ≈ $292.46 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Green Cross Lab Cell Corporation - Cash Flow Conversion Efficiency Trend (2015–2024)

This chart illustrates how Green Cross Lab Cell Corporation's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read how much debt does Green Cross Lab Cell Corporation carry for a breakdown of total debt and financial obligations.

Green Cross Lab Cell Corporation Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Green Cross Lab Cell Corporation ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Roman DBDR Acquisition Corp. II Ordinary shares NASDAQ:DRDB	-0.001x
Vine Hill Capital Investment Corp. Class A Ordinary Shares NASDAQ:VCIC	0.071x
Mitrabahtera Segara Sejati Tbk JK:MBSS	49.540x
DCX Systems Limited NSE:DCXINDIA	0.002x
Supermax Corporation Bhd KLSE:7106	0.001x
Nam Viet Corp VN:ANV	-0.041x
Victoria Care Indonesia Tbk Pt JK:VICI	0.042x
Nusantara Infrastructure Tbk JK:META	0.015x

Annual Cash Flow Conversion Efficiency for Green Cross Lab Cell Corporation (2015–2024)

The table below shows the annual cash flow conversion efficiency of Green Cross Lab Cell Corporation from 2015 to 2024. For the full company profile with market capitalisation and key ratios, see Green Cross Lab Cell Corporation market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩457.79 Billion ≈ $310.24 Million	₩11.34 Billion ≈ $7.69 Million	0.025x	+265.48%
2023-12-31	₩541.48 Billion ≈ $366.95 Million	₩3.67 Billion ≈ $2.49 Million	0.007x	-94.50%
2022-12-31	₩538.46 Billion ≈ $364.91 Million	₩66.42 Billion ≈ $45.01 Million	0.123x	+163.63%
2021-12-31	₩511.00 Billion ≈ $346.30 Million	₩23.91 Billion ≈ $16.20 Million	0.047x	-75.73%
2020-12-31	₩47.17 Billion ≈ $31.97 Million	₩9.09 Billion ≈ $6.16 Million	0.193x	+3707.58%
2019-12-31	₩44.05 Billion ≈ $29.85 Million	₩223.04 Million ≈ $151.15K	0.005x	-50.78%
2018-12-31	₩47.72 Billion ≈ $32.34 Million	₩490.92 Million ≈ $332.69K	0.010x	-82.63%
2017-12-31	₩48.32 Billion ≈ $32.75 Million	₩2.86 Billion ≈ $1.94 Million	0.059x	+1059.97%
2016-12-31	₩48.10 Billion ≈ $32.59 Million	₩-296.65 Million ≈ $-201.04K	-0.006x	-103.71%
2015-12-31	₩8.96 Billion ≈ $6.07 Million	₩1.49 Billion ≈ $1.01 Million	0.166x	--

About Green Cross Lab Cell Corporation

KQ:144510 Korea Diagnostics & Research

Market Cap

$241.86 Million

₩356.89 Billion KRW

Market Cap Rank

#15826 Global

#627 in Korea

Share Price

₩23750.00

Change (1 day)

-2.66%

52-Week Range

₩18280.00 - ₩27500.00

All Time High

₩126167.70